What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Yair Lotan mainly focuses on Bladder cancer, Surgery, Internal medicine, Cystectomy and Urology.
His Bladder cancer study combines topics in areas such as Stage, Urinary bladder and Carcinoma, Pathology.
His work carried out in the field of Surgery brings together such families of science as Lymphadenectomy, Intensive care medicine, Nomogram, Nephrectomy and Disease.
His Internal medicine study incorporates themes from Gynecology and Oncology.
As part of one scientific family, Yair Lotan deals mainly with the area of Cystectomy, narrowing it down to issues related to the Neoadjuvant therapy, and often Chemotherapy.
His studies deal with areas such as Lymphovascular invasion, Carcinoma in situ, Urine cytology, Biopsy and TNM staging system as well as Urology.
His most cited work include:
- Comprehensive molecular characterization of urothelial bladder carcinoma (1756 citations)
- Epidemiology and risk factors of urothelial bladder cancer (1002 citations)
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer (865 citations)
What are the main themes of his work throughout his whole career to date?
Yair Lotan mainly investigates Internal medicine, Bladder cancer, Oncology, Urology and Surgery.
He works in the field of Bladder cancer, namely Cystectomy.
His research in Oncology intersects with topics in Tissue microarray, Chemotherapy, Cohort and Hazard ratio.
Yair Lotan combines subjects such as Lymphovascular invasion, Carcinoma in situ, Carcinoma, Transitional cell carcinoma and Proportional hazards model with his study of Urology.
Yair Lotan regularly ties together related areas like Nephrectomy in his Surgery studies.
Cancer research is closely connected to Pathology in his research, which is encompassed under the umbrella topic of Cancer.
He most often published in these fields:
- Internal medicine (42.97%)
- Bladder cancer (35.54%)
- Oncology (32.28%)
What were the highlights of his more recent work (between 2018-2021)?
- Bladder cancer (35.54%)
- Internal medicine (42.97%)
- Oncology (32.28%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Bladder cancer, Internal medicine, Oncology, Urology and Cystectomy.
Yair Lotan works mostly in the field of Bladder cancer, limiting it down to concerns involving Cystoscopy and, occasionally, Cytology and Prospective cohort study.
His research on Internal medicine often connects related topics like Gastroenterology.
His Oncology research includes elements of Stage, Metastatic Urothelial Carcinoma, Disease and Immunotherapy.
His Urology research is multidisciplinary, incorporating elements of Carcinoma in situ, Urine, Prostate and Prostate cancer.
His Cystectomy research is multidisciplinary, relying on both Basal, Clinical trial and Cohort.
Between 2018 and 2021, his most popular works were:
- Molecular Characterization of Neuroendocrine-like Bladder Cancer (33 citations)
- Molecular markers in bladder cancer (29 citations)
- Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer (29 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His main research concerns Bladder cancer, Internal medicine, Cystectomy, Oncology and Urology.
His research integrates issues of Flexible cystoscopy, Cystoscopy, Lymphovascular invasion and Clinical trial in his study of Bladder cancer.
His work on Internal medicine deals in particular with Cancer, Disease, Retroperitoneal lymph node dissection, Immunohistochemistry and Carcinoma.
His Cystectomy study combines topics from a wide range of disciplines, such as Chemotherapy, Induction chemotherapy, Cohort, Retrospective cohort study and Concomitant.
The various areas that Yair Lotan examines in his Oncology study include Basal, Chemotherapy naive, Hazard ratio, Survival analysis and Human genetics.
His Urology research integrates issues from Neoadjuvant therapy, Carcinoma in situ, Survival rate, Extraprostatic extension and Proportional hazards model.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
